US Stock MarketDetailed Quotes
BLTE Belite Bio
- 39.750
- +1.750+4.61%
Close Apr 26 16:00 ET
1.18BMarket Cap-33403P/E (TTM)
40.220High38.110Low46.60KVolume38.110Open38.000Pre Close1.84MTurnover0.39%Turnover RatioLossP/E (Static)29.75MShares48.60052wk High13.08P/B469.64MFloat Cap11.00052wk Low--Dividend TTM11.81MShs Float48.600Historical High--Div YieldTTM5.55%Amplitude8.800Historical Low39.447Avg Price1Lot Size
Belite Bio Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||
| Cash flow from continuing operating activities | -160.40%-29.84M | -53.30%-11.46M | -68.26%-7.47M | -4.44M |
| Net income from continuing operations | -150.09%-31.63M | -30.85%-12.65M | -68.02%-9.67M | ---5.75M |
| Operating gains losses | ---- | ---- | ---8K | ---- |
| Depreciation and amortization | 101.52%399K | 560.00%198K | 76.47%30K | --17K |
| Change In working capital | -394.30%-2.43M | -176.72%-491K | 1,027.54%640K | ---69K |
| -Change in receivables | -125.00%-72K | ---32K | --0 | --4K |
| -Change in prepaid assets | -390.56%-3.53M | -1,845.95%-720K | -118.50%-37K | --200K |
| -Change in payables and accrued expense | 328.01%1.42M | -50.96%332K | 347.99%677K | ---273K |
| -Change in other current liabilities | -243.66%-244K | ---71K | --0 | --0 |
| Cash from discontinued investing activities | ||||
| Operating cash flow | -160.40%-29.84M | -53.30%-11.46M | -68.26%-7.47M | ---4.44M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 84.01%-63K | -603.57%-394K | -180.00%-56K | -20K |
| Net PPE purchase and sale | 84.01%-63K | -603.57%-394K | -180.00%-56K | ---20K |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 84.01%-63K | -603.57%-394K | -180.00%-56K | ---20K |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 105.50%75.96M | 6,440.14%36.96M | -102.08%-583K | 28.06M |
| Net issuance payments of debt | ---- | ---- | ---- | ---2.32M |
| Net common stock issuance | --0 | --37.99M | --0 | --500K |
| Net preferred stock issuance | ---- | ---- | ---- | --29.79M |
| Proceeds from stock option exercised by employees | 733,266.67%22M | -98.71%3K | 169.77%232K | --86K |
| Net other financing activities | 5,338.64%53.96M | -26.38%-1.03M | ---815K | ---- |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 105.50%75.96M | 6,440.14%36.96M | -102.08%-583K | --28.06M |
| Net cash flow | ||||
| Beginning cash position | 142.67%42.09M | -32.30%17.34M | 1,170.10%25.62M | --2.02M |
| Current changes in cash | 83.42%46.06M | 409.52%25.11M | -134.38%-8.11M | --23.6M |
| Effect of exchange rate changes | 102.46%9K | -127.33%-366K | -4,125.00%-161K | --4K |
| End cash Position | 109.45%88.16M | 142.67%42.09M | -32.30%17.34M | --25.62M |
| Free cash flow | -152.28%-29.9M | -57.02%-11.85M | -69.16%-7.55M | ---4.46M |
| Currency Unit | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg